Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Deltek, Inc (“Deltek” or the “Company”) (Nasdaq: PROJ) relating to the proposed acquisition by Thoma Bravo, LLC. (“Thoma Bravo”). Under the terms of the transaction, Deltek shareholders will receive only $13.00 in cash for each share of Deltek stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Deltek for not acting in the Company’s shareholders' best interests in connection with the sale process to Thoma Bravo. The transaction may undervalue the Company as Deltek stock traded at $14.25 a share as recently as August 21, 2012. In addition, an analyst has set a price target on Deltek stock at $16.00 per share. If you own shares of Deltek stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org visiting http://brodsky-smith.com/472-proj-deltek-inc.html, or by calling toll free 877-LEGAL-90.
Gregg Greenberg breaks down today's market action. Guests include Vikram Mansharamani, author of "Boombustology", David Peltier, TheStreet's Stocks Under $10 portfolio manager and Alison Lovett, vice president at Van Eck Global.